Gurvinder Singh

Gurvinder Singh

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2023 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
SYSachin Yadav
Sachin Yadav
AKAbhai Kumar
Abhai Kumar
SSSmita Singh
Smita Singh
SAShahnawaz Ahmad
Shahnawaz Ahmad
GSGurvinder Singh
Gurvinder Singh
DKDinesh Kumar
Dinesh Kumar

22 July 2025 in Toxicology
Verified
Journal Article
Closed access
GVG. Vigneshwaran
G. Vigneshwaran
IDItishree Dubey
Itishree Dubey
AKAnand Kumar
Anand Kumar
LALalruatmawii
Lalruatmawii
AHAditya Hyalij
Aditya Hyalij
SKSapana Kushwaha
Sapana Kushwaha

8 August 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Anand KumarAnand Kumar
Anand Kumar
PPPriyanka Prajapati
Priyanka Prajapati
GSGurvinder Singh
Gurvinder Singh
DKDinesh Kumar
Dinesh Kumar
VMVikas Mishra
Vikas Mishra
SKSapana Kushwaha
Sapana Kushwaha
Type 2 diabetes is a metabolic disorder that leads to accelerated skeletal muscle atrophy. In this study, we aimed to evaluate the effect of salbutamol (SLB) on skeletal muscle atrophy in high-fat diet (HFD)/streptozotocin (STZ)-induced diabetic rats. Male Sprague Dawley rats were divided into four groups (n = 6): control, SLB, HFD/STZ, and HFD/STZ + SLB (6 mg/kg orally for four weeks). After the last dose of SLB, rats were assessed for muscle grip strength and muscle coordination (wire-hanging, rotarod, footprint, and actophotometer tests). Body composition was analyzed in live rats. After that, animals were sacrificed, and serum and gastrocnemius (GN) muscles were collected. Endpoints include myofibrillar protein content, muscle oxidative stress and antioxidants, serum pro-inflammatory cytokines (interleukin-1β, interleukin-2, and interleukin-6), serum muscle markers (myostatin, creatine kinase, and testosterone), histopathology, and muscle 1H NMR metabolomics. Findings showed that SLB treatment significantly improved muscle strength and muscle coordination, as well as increased lean muscle mass in diabetic rats. Increased pro-inflammatory cytokines and muscle markers (myostatin, creatine kinase) indicate muscle deterioration in diabetic rats, while SLB intervention restored the same. Also, Feret’s diameter and cross-sectional area of GN muscle were increased by SLB treatment, indicating the amelioration in diabetic rat muscle. Results of muscle metabolomics exhibit that SLB treatment resulted in the restoration of perturbed metabolites, including histidine-to-tyrosine, phenylalanine-to-tyrosine, and glutamate-to-glutamine ratios and succinate, sarcosine, and 3-hydroxybutyrate (3HB) in diabetic rats. These metabolites showed a pertinent role in muscle inflammation and oxidative stress in diabetic rats. In conclusion, findings showed that salbutamol could be explored as an intervention in diabetic-associated skeletal muscle atrophy.

25 July 2025 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
PSPrashant Sharma
Prashant Sharma
SDSakshi Dagariya
Sakshi Dagariya
GSGurvinder Singh
Gurvinder Singh
DKDinesh Kumar
Dinesh Kumar
MSManish Singh
Manish Singh
Illustration showing the synthesis of NPs from PET plastic bottle and their toxicological assessment across three in vitro models: L. rhamnosus, red blood cells, and A549 cells. Icons adapted from Bioicons and Servier Medical Art.

21 August 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GSGurvinder Singh
Gurvinder Singh
SASakir Ahmed
Sakir Ahmed
DDDurgesh Dubey
Durgesh Dubey
MRMohit Kumar Rai
Mohit Kumar Rai
ARAtul Rawat
Atul Rawat
DKDinesh Kumar
Dinesh Kumar
Systemic Sclerosis (SSc) is a complex autoimmune disorder characterized by vascular dysfunction, immune dysregulation, and progressive fibrosis of the skin and internal organs. Despite substantial research, its pathophysiology remains enigmatic, necessitating the identification of altered metabolic pathways to improve disease management. This study utilized NMR-based serum metabolomics to identify distinctive metabolic signatures and deranged pathways in SSc. 1D 1H CPMG spectra of sera from 83 SSc patients and 43 age/sex matched HC were measured using 800 MHz NMR. Spectral binning and concentration profiling data were analyzed using multivariate statistical analysis to identify discriminatory metabolic features based variable importance in projection (VIP) scores and mean decrease accuracy (MDA). Univariate statistical analysis and receiver operating characteristic (ROC) curve analysis further evaluated their diagnostic potential. Multivariate analysis revealed clear differentiation between SSc and HC. SSc patients showed decreased levels of alanine, valine, myo-inositol, creatinine, pyruvate, lactate, PUFA, LDL/VLDL, and lipids, alongside elevated levels of acetate, 3-hydroxybutyrate, and mannose. Twelve key metabolites demonstrated high sensitivity and specificity in distinguishing SSc from HC. Pathway analysis revealed disruptions in sugar metabolism, branched-chain amino acids, fatty acid metabolism, and energy metabolism. These findings underscore NMR-based metabolomics as a promising tool for improving SSc diagnosis and understanding its pathogenesis, paving the way for targeted therapeutic strategies.

20 August 2025 in Magnetic Resonance in Chemistry
Verified
Journal Article
Closed access
GSGurvinder Singh
Gurvinder Singh
MRMohit Kumar Rai
Mohit Kumar Rai
VAVikas Agarwal
Vikas Agarwal
DKDinesh Kumar
Dinesh Kumar